Kudo H, Suga M, Waga T, Ogasawara M, Sato T, Usubuchi I
Tohoku J Exp Med. 1980 Jan;130(1):49-53. doi: 10.1620/tjem.130.49.
Experimental immunotherapy with a mixture of allogeneic tumor cells and BCG cell-wall skeleton (BCG-CWS) was carried out against established autochthonous fibrosarcomas induced by 3-methylcholanthrene (MCA) in the subcutaneous tissue of rats. The inhibitory effect on growth in the early stage, tumor-size up to 2 cm in diameter, was significantly observed. No significant difference, however, was shown as compared with the effect of treatment with allogeneic tumor cells alone. That is to say, a more effective inhibition of growth due to the addition of BCG-CWS was not demonstrated.
采用同种异体肿瘤细胞与卡介苗细胞壁骨架(BCG-CWS)的混合物对大鼠皮下组织中由3-甲基胆蒽(MCA)诱导产生的移植性纤维肉瘤进行实验性免疫治疗。在早期阶段,即肿瘤直径达2厘米时,观察到对肿瘤生长有显著的抑制作用。然而,与单独使用同种异体肿瘤细胞治疗的效果相比,未显示出显著差异。也就是说,未证明添加BCG-CWS能更有效地抑制肿瘤生长。